MAPT and Alzheimer disease: In line with previous studies showing less abnormal amyloid and tau CSF biomarkers [9] and negative tau-PET scans [8, 25], patients in our cohort with a LATE-like pattern showed significantly less tau load in AD-related regions than AD-like cases, but no differences in amyloid.